<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cefazolin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:32 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="filelist-111.xml.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Cefazolin_files/filelist.xml">
<link rel=Edit-Time-Data href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Cefazolin_files/editdata.mso  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Cefazolin_files/editdata.mso'" tppabs="http://www.vietstarse.com/duocthu/Documents/Cefazolin_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>CEFAZOLIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>5</o:TotalTime>
  <o:Created>2006-08-08T14:03:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:20:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>2197</o:Words>
  <o:Characters>12525</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>104</o:Lines>
  <o:Paragraphs>29</o:Paragraphs>
  <o:CharactersWithSpaces>14693</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>CEFAZOLIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Cefazolin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> J01D A04.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Kháng sinh
cephalosporin th&#7871; h&#7879; 1.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7885; 0,25 g, 0,50 g, 1 g b&#7897;t vô khu&#7849;n &#273;&#7875;
pha tiêm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dung môi pha tiêm b&#7855;p: N&#432;&#7899;c c&#7845;t pha tiêm, natri
clorid tiêm 0,9%, dextrose tiêm 5%, lidocain tiêm 5%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dung môi pha tiêm t&#297;nh m&#7841;ch và tiêm truy&#7873;n: <span
style='letter-spacing:-.1pt'>N&#432;&#7899;c c&#7845;t pha tiêm, natri clorid
tiêm 0,9%, dextrose tiêm 5% ho&#7863;c 10%, dextrose 5% trong natri lactat
tiêm, dextrose tiêm 5% có thêm natri clorid tiêm 0,9% ho&#7863;c 0,45% ho&#7863;c
0,2%, natri lactat tiêm, &#273;&#432;&#7901;ng chuy&#7875;n 5% hay 10% trong
n&#432;&#7899;c c&#7845;t pha tiêm, dung d&#7883;ch &#273;&#432;&#7901;ng ngh&#7883;ch
chuy&#7875;n 5% ho&#7863;c 10% trong n&#432;&#7899;c &#273;&#7875; tiêm.</span><o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin là kháng sinh nhóm cephalosporin &quot;th&#7871; h&#7879;
1&quot;, tác &#273;&#7897;ng kìm hãm s&#7921; phát tri&#7875;n và phân chia vi
khu&#7849;n b&#7857;ng cách &#7913;c ch&#7871; t&#7893;ng h&#7907;p v&#7887; t&#7871;
bào vi khu&#7849;n. Cefazolin có tác d&#7909;ng m&#7841;nh trong các b&#7879;nh
nhi&#7877;m khu&#7849;n Gram d&#432;&#417;ng do <i>Staphylococcus aureus</i> (k&#7875;
c&#7843; ch&#7911;ng ti&#7871;t penicilinase), <i>Staphylococcus epidermidis,
Streptococcus beta - hemolyticus</i> nhóm A, <i>Streptococcus pneumoniae</i> và
các ch&#7911;ng <i>Streptococcus </i>khác (nhi&#7873;u ch&#7911;ng <i>Enterococcus</i>
kháng cefazolin).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Theo s&#7889; li&#7879;u ASTS 1996 - 1997, tính kháng thu&#7889;c c&#7911;a
các vi khu&#7849;n gây b&#7879;nh th&#432;&#7901;ng g&#7863;p &#273;&#7889;i v&#7899;i
cefalotin và cefazolin là t&#432;&#417;ng t&#7921; nhau.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7889;i v&#7899;i nhi&#7873;u vi khu&#7849;n Gram d&#432;&#417;ng,
hi&#7879;u qu&#7843; tác d&#7909;ng c&#7911;a cefazolin v&#7851;n khá. T&#7881;
l&#7879; gi&#7919;a nh&#7841;y c&#7843;m/kháng <span style='letter-spacing:
-.05pt'>thu&#7889;c c&#7911;a <i>S. aureus</i> là 72 - 94%/2 - 17%; c&#7911;a <i>S.
epider</i></span><i>midis</i> là 89%/8%; c&#7911;a <i>Streptococcus beta
hemolyticus</i> nhóm A là 66 - 83%/8 - 18%, nh&#432;ng &#7903; b&#7879;nh vi&#7879;n
Hai Bà Tr&#432;ng Hà N&#7897;i t&#7881; l&#7879; này là 17%/50%; v&#7899;i <i>Streptococcus
pneumoniae</i> là 70 - 90%/1 - 17%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Cefazolin c&#361;ng có tác d&#7909;ng trên m&#7897;t
s&#7889; ít tr&#7921;c khu&#7849;n Gram âm &#432;a khí nh&#432;: <i>Escherichia
coli, Klebsiella sp., Proteus mirabilis</i> và <i>Haemophilus influenzae</i>.
Tuy nhiên, s&#7921; kháng thu&#7889;c ngày càng t&#259;ng: <i>E. coli</i> có t&#7927;
l&#7879; kháng là 53% trên c&#7843; n&#432;&#7899;c, 78% &#7903; mi&#7873;n
nam, 61% &#7903; mi&#7873;n trung và 46% &#7903; b&#7879;nh vi&#7879;n B&#7841;ch
Mai. <i>Klebsiella pneumoniae</i> có t&#7927; l&#7879; kháng trên c&#7843;
n&#432;&#7899;c là 66%. <i>Proteus mirabilis</i> có t&#7881; l&#7879; kháng 66%
&#7903; b&#7879;nh vi&#7879;n</span><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> Vi&#7879;t Nam - Cu Ba (1994 -
1995) và 65% &#7903; b&#7879;nh vi&#7879;n Ch&#7907; R&#7851;y (1992 - 1996).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H. influenzae</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> có t&#7881; l&#7879; nh&#7841;y c&#7843;m
cao h&#417;n, theo th&#7889;ng kê nh&#7841;y c&#7843;m là 88 - 90% và kháng là
5 - 10% &#7903; b&#7879;nh vi&#7879;n Thái Nguyên (1992 - 1994) và b&#7879;nh
vi&#7879;n huy&#7879;n Qu&#7843;ng X&#432;&#417;ng (1991 - 1993). Nh&#432;ng t&#7881;
l&#7879; kháng là 18% &#7903; B&#7879;nh vi&#7879;n Trung &#432;&#417;ng Hu&#7871;
(1988 - 1991) và 22% &#7903; b&#7879;nh vi&#7879;n &#273;a khoa Yên Bái (1993 -
1995). N&#259;m 1996,<i> </i>t&#7881; l&#7879; kháng chung c&#7843; n&#432;&#7899;c
là 9%, trong &#273;ó b&#7879;nh vi&#7879;n B&#7841;ch Mai là 40%; B&#7879;nh vi&#7879;n
Trung &#432;&#417;ng Hu&#7871; là 0%; vi&#7879;n nhi Th&#7909;y Ði&#7875;n là
6%).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin không có tác d&#7909;ng v&#7899;i <i>Enterococcus faecalis</i>.
Nh&#7919;ng tr&#7921;c khu&#7849;n Gram âm &#432;a khí khác (th&#432;&#7901;ng
phát hi&#7879;n &#7903; các b&#7879;nh vi&#7879;n nh&#432; <i>Enterobacter </i>spp<i>.,
Pseudomonas </i>spp.) &#273;&#7873;u kháng thu&#7889;c. Nh&#7919;ng vi khu&#7849;n
k&#7925; khí phân l&#7853;p &#273;&#432;&#7907;c &#7903; mi&#7879;ng - h&#7847;u
nói chung &#273;&#7873;u nh&#7841;y c&#7843;m, tuy v&#7853;y nh&#7919;ng vi khu&#7849;n
k&#7925; khí nh&#432; <i>Bacteroides fragilis</i> thì l&#7841;i kháng thu&#7889;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các cephalosporin th&#7871; h&#7879; 1 &#273;&#7873;u không có tác d&#7909;ng
v&#7899;i các vi khu&#7849;n Gram âm &#432;a khí nh&#432; <i>Serratia,</i> <i>Enterobacter
</i>ho&#7863;c <i>Pseudomonas.<o:p></o:p></i></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7891;ng &#273;&#7897; &#7913;c ch&#7871; t&#7889;i thi&#7875;u c&#7911;a
cefazolin v&#7899;i các c&#7847;u khu&#7849;n Gram d&#432;&#417;ng nh&#7841;y c&#7843;m
là 0,1 &#273;&#7871;n 1 microgam/ml; v&#7899;i ph&#7847;n l&#7899;n các vi khu&#7849;n
Gram âm nh&#7841;y c&#7843;m thì n&#7891;ng &#273;&#7897; c&#7847;n ph&#7843;i
l&#7899;n h&#417;n 1 microgam/ml.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin &#273;&#432;&#7907;c h&#7845;p thu kém t&#7915; &#273;&#432;&#7901;ng
ru&#7897;t nên ph&#7843;i &#273;&#432;&#7907;c s&#7917; d&#7909;ng qua
&#273;&#432;&#7901;ng tiêm m&#7863;c dù tiêm b&#7855;p gây &#273;au. V&#7899;i
li&#7873;u tiêm b&#7855;p 500 mg cefazolin n&#7891;ng &#273;&#7897; &#273;&#7881;nh
&#273;&#7841;t &#273;&#432;&#7907;c trong huy&#7871;t t&#432;&#417;ng là t&#7915;
30 microgam/ml tr&#7903; lên sau 1 &#273;&#7871;n 2 gi&#7901;. Kho&#7843;ng 85%
cefazolin trong máu liên k&#7871;t v&#7899;i protein huy&#7871;t
t&#432;&#417;ng. N&#7917;a &#273;&#7901;i c&#7911;a cefazolin trong huy&#7871;t
t&#432;&#417;ng là kho&#7843;ng 1,8 gi&#7901; và có th&#7875; t&#259;ng t&#7915;
20 &#273;&#7871;n 70 gi&#7901; &#7903; nh&#7919;ng ng&#432;&#7901;i b&#7883;
suy th&#7853;n. Cefazolin khu&#7871;ch tán vào x&#432;&#417;ng, vào các d&#7883;ch
c&#7893; tr&#432;&#7899;ng, màng ph&#7893;i và ho&#7841;t d&#7883;ch,
nh&#432;ng khu&#7871;ch tán kém vào d&#7883;ch não t&#7911;y. Cefazolin &#273;i
qua nhau thai vào tu&#7847;n hoàn thai nhi; bài ti&#7871;t trong s&#7919;a m&#7865;
v&#7899;i n&#7891;ng &#273;&#7897; r&#7845;t th&#7845;p. Cefazolin &#273;&#432;&#7907;c
&#273;ào th&#7843;i qua n&#432;&#7899;c ti&#7875;u &#7903; d&#7841;ng không
&#273;&#7893;i, ph&#7847;n l&#7899;n qua l&#7885;c c&#7847;u th&#7853;n và m&#7897;t
ph&#7847;n nh&#7887; qua bài ti&#7871;t &#7903; &#7889;ng th&#7853;n. ÍT nh&#7845;t
80% li&#7873;u tiêm b&#7855;p &#273;&#432;&#7907;c &#273;ào th&#7843;i qua
n&#432;&#7899;c ti&#7875;u trong 24 gi&#7901;. V&#7899;i li&#7873;u tiêm b&#7855;p
500 mg và 1 g, cefazolin &#273;&#7841;t n&#7891;ng &#273;&#7897; &#273;&#7881;nh
trong n&#432;&#7899;c ti&#7875;u t&#432;&#417;ng &#7913;ng cao h&#417;n 1 mg/ml
và 4 mg/ml. Probenecid làm ch&#7853;m vi&#7879;c &#273;ào th&#7843;i c&#7911;a
cefazolin. Cefazolin &#273;&#432;&#7907;c lo&#7841;i b&#7887; &#7903; m&#7897;t
m&#7913;c &#273;&#7897; nào &#273;ó qua th&#7849;m tách máu. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin có n&#7891;ng &#273;&#7897; cao trong m&#7853;t m&#7863;c dù
s&#7889; l&#432;&#7907;ng bài ti&#7871;t qua m&#7853;t ít.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh trong &#273;i&#7873;u
tr&#7883; các b&#7879;nh nhi&#7877;m khu&#7849;n sau:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n &#273;&#432;&#7901;ng hô h&#7845;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Nhi&#7877;m khu&#7849;n da và mô m&#7873;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Nhi&#7877;m khu&#7849;n x&#432;&#417;ng và kh&#7899;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>M&#7897;t s&#7889; tr&#432;&#7901;ng h&#7907;p
nhi&#7877;m khu&#7849;n huy&#7871;t và viêm n&#7897;i tâm m&#7841;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>M&#7897;t s&#7889; tr&#432;&#7901;ng h&#7907;p
nhi&#7877;m khu&#7849;n &#273;&#432;&#7901;ng m&#7853;t và ti&#7871;t ni&#7879;u
sinh d&#7909;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Tuy nhiên t&#7889;t nh&#7845;t v&#7851;n là
&#273;i&#7873;u tr&#7883; theo kháng sinh &#273;&#7891;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ði&#7873;u tr&#7883; d&#7921; phòng: S&#7917; d&#7909;ng
cefazolin trong ph&#7851;u thu&#7853;t có th&#7875; làm gi&#7843;m t&#7881; l&#7879;
nhi&#7877;m khu&#7849;n h&#7853;u ph&#7851;u &#7903; nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh &#273;ang tr&#7843;i qua nh&#7919;ng ph&#7851;u thu&#7853;t có nguy
c&#417; nhi&#7877;m khu&#7849;n cao, ho&#7863;c ph&#7851;u thu&#7853;t nh&#7919;ng
ch&#7895; có th&#7875; x&#7843;y ra nhi&#7877;m khu&#7849;n h&#7853;u ph&#7851;u
&#273;&#7863;c bi&#7879;t nghiêm tr&#7885;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh &#273;&#7889;i
v&#7899;i ng&#432;&#7901;i b&#7879;nh có ti&#7873;n s&#7917; d&#7883; &#7913;ng
v&#7899;i kháng sinh nhóm cephalosporin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Tr&#432;&#7899;c khi b&#7855;t &#273;&#7847;u
&#273;i&#7873;u tr&#7883; b&#7857;ng cefazolin, ph&#7843;i &#273;i&#7873;u tra
k&#7929; v&#7873; ti&#7873;n s&#7917; d&#7883; &#7913;ng c&#7911;a ng&#432;&#7901;i
b&#7879;nh v&#7899;i cephalosporin, penicilin ho&#7863;c thu&#7889;c khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'>Ðã có d&#7845;u hi&#7879;u
cho th&#7845;y có d&#7883; &#7913;ng chéo m&#7897;t ph&#7847;n gi&#7919;a
penicilin và cephalosporin. Ðã có thông báo v&#7873; nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh có nh&#7919;ng ph&#7843;n &#7913;ng tr&#7847;m tr&#7885;ng (k&#7875;
c&#7843; s&#7889;c ph&#7843;n v&#7879;) v&#7899;i c&#7843; hai lo&#7841;i thu&#7889;c.
T&#7889;t h&#417;n là nên tránh dùng cephalosporin cho ng&#432;&#7901;i b&#7879;nh
có ti&#7873;n s&#7917; b&#7883; ph&#7843;n v&#7879; do penicilin ho&#7863;c b&#7883;
ph&#7843;n &#7913;ng tr&#7847;m tr&#7885;ng khác qua trung gian globulin mi&#7877;n
d&#7883;ch IgE.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>N&#7871;u có ph&#7843;n &#7913;ng d&#7883; &#7913;ng
v&#7899;i cefazolin, ph&#7843;i ng&#7915;ng thu&#7889;c và ng&#432;&#7901;i b&#7879;nh
c&#7847;n &#273;&#432;&#7907;c x&#7917; lý b&#7857;ng các thu&#7889;c th&#432;&#7901;ng
dùng (nh&#432; adrenalin ho&#7863;c các amin co m&#7841;ch, kháng histamin, ho&#7863;c
corticosteroid).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>C&#7847;n th&#7853;n tr&#7885;ng khi kê
&#273;&#417;n các kháng sinh ph&#7893; r&#7897;ng cho nh&#7919;ng ng&#432;&#7901;i
có b&#7879;nh s&#7917; v&#7873; d&#7841; dày ru&#7897;t, &#273;&#7863;c bi&#7879;t
là b&#7879;nh viêm &#273;&#7841;i tràng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>S&#7917; d&#7909;ng cefazolin dài ngày có th&#7875;
làm phát tri&#7875;n quá m&#7913;c các vi khu&#7849;n không nh&#7841;y c&#7843;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>C&#7847;n ph&#7843;i theo dõi ng&#432;&#7901;i b&#7879;nh
c&#7849;n th&#7853;n. N&#7871;u b&#7897;i nhi&#7877;m trong khi &#273;i&#7873;u
tr&#7883;, c&#7847;n có nh&#7919;ng bi&#7879;n pháp thích h&#7907;p. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Khi dùng cefazolin cho ng&#432;&#7901;i b&#7879;nh
suy ch&#7913;c n&#259;ng th&#7853;n c&#7847;n gi&#7843;m li&#7873;u s&#7917; d&#7909;ng
hàng ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Vi&#7879;c dùng cefazolin qua &#273;&#432;&#7901;ng
tiêm vào d&#7883;ch não t&#7911;y ch&#432;a &#273;&#432;&#7907;c ch&#7845;p nh&#7853;n.
Ðã có nh&#7919;ng báo cáo v&#7873; bi&#7875;u hi&#7879;n nhi&#7877;m &#273;&#7897;c
n&#7863;ng trên th&#7847;n kinh trung &#432;&#417;ng, k&#7875; c&#7843; nh&#7919;ng
c&#417;n co gi&#7853;t, khi tiêm cefazolin theo &#273;&#432;&#7901;ng này.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Các nghiên c&#7913;u v&#7873; kh&#7843; n&#259;ng
sinh s&#7843;n trên chu&#7897;t nh&#7855;t, chu&#7897;t c&#7889;ng và th&#7887;
v&#7899;i các li&#7873;u cao g&#7845;p 25 l&#7847;n li&#7873;u dùng cho
ng&#432;&#7901;i không cho th&#7845;y d&#7845;u hi&#7879;u t&#7893;n
th&#432;&#417;ng kh&#7843; n&#259;ng sinh s&#7843;n ho&#7863;c có h&#7841;i cho
bào thai.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cefazolin th&#432;&#7901;ng &#273;&#432;&#7907;c
xem nh&#432; có th&#7875; s&#7917; d&#7909;ng an toàn cho ng&#432;&#7901;i mang
thai. Có th&#7875; tiêm t&#297;nh m&#7841;ch 2 g cefazolin, cách 8 gi&#7901;/l&#7847;n,
&#273;&#7875; &#273;i&#7873;u tr&#7883; viêm th&#7853;n - b&#7875; th&#7853;n
cho ng&#432;&#7901;i mang thai trong n&#7917;a cu&#7889;i thai k&#7923;.
Ch&#432;a th&#7845;y tác d&#7909;ng có h&#7841;i &#273;&#7889;i v&#7899;i bào
thai do thu&#7889;c gây nên. Tuy v&#7853;y, ch&#432;a có nh&#7919;ng nghiên c&#7913;u
&#273;&#7847;y &#273;&#7911; và ki&#7875;m soát ch&#7863;t ch&#7869; trên nh&#7919;ng
ng&#432;&#7901;i mang thai. Vì các nghiên c&#7913;u v&#7873; kh&#7843;
n&#259;ng sinh s&#7843;n trên súc v&#7853;t, không ph&#7843;i lúc nào c&#361;ng
tiên &#273;oán &#273;&#432;&#7907;c các &#273;áp &#7913;ng &#7903; ng&#432;&#7901;i,
nên thu&#7889;c này ch&#7881; dùng cho ng&#432;&#7901;i mang thai khi th&#7853;t
c&#7847;n thi&#7871;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>N&#7891;ng &#273;&#7897; cefazolin trong s&#7919;a
m&#7865; tuy th&#7845;p, nh&#432;ng v&#7851;n có ba v&#7845;n &#273;&#7873; ti&#7873;m
tàng có th&#7875; x&#7843;y ra &#7903; tr&#7867;: S&#7921; thay &#273;&#7893;i
c&#7911;a h&#7879; vi khu&#7849;n &#273;&#432;&#7901;ng ru&#7897;t, tác d&#7909;ng
tr&#7921;c ti&#7871;p lên tr&#7867; &#273;ang bú, và k&#7871;t qu&#7843; s&#7869;
b&#7883; nhi&#7877;u khi c&#7847;n th&#7917; kháng sinh &#273;&#7891; &#7903;
tr&#7867; b&#7883; s&#7889;t. C&#7847;n ph&#7843;i quan sát các ch&#7913;ng &#7881;a
ch&#7843;y, t&#432;a l&#432;&#7905;i do n&#7845;m <i>Candida</i> và n&#7893;i
ban &#7903; tr&#7867; bú s&#7919;a c&#7911;a m&#7865; &#273;ang dùng cefazolin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR) <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú: </span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ðã có thông báo v&#7873; d&#7883; &#7913;ng
v&#7899;i cefazolin &#7903; ng&#432;&#7901;i b&#7879;nh không b&#7883; d&#7883;
&#7913;ng v&#7899;i penicilin, nh&#432;ng không rõ t&#7881; l&#7879; chính xác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>G&#7847;n &#273;ây &#273;ã có thông báo v&#7873; nh&#7919;ng tr&#432;&#7901;ng
h&#7907;p b&#7883; ho&#7841;i t&#7917; bi&#7875;u bì nhi&#7877;m &#273;&#7897;c
và nhi&#7873;u thông báo v&#7873; ban m&#7909;n m&#7911; phát tri&#7875;n toàn
thân do cefazolin. &#431;&#7899;c tính t&#7881; l&#7879; xác th&#7921;c b&#7883;
d&#7883; &#7913;ng chéo lâm sàng gi&#7919;a penicilin và cephalosporin là 1
&#273;&#7871;n 2%. Tuy nhiên, t&#7889;t h&#417;n là nên tránh dùng
cephalosporin trong tr&#432;&#7901;ng h&#7907;p có ti&#7873;n s&#7917; b&#7883;
ph&#7843;n v&#7879; do penicilin ho&#7863;c ph&#7843;n &#7913;ng tr&#7847;m tr&#7885;ng
khác qua trung gian globulin mi&#7877;n d&#7883;ch IgE.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H&#7847;u nh&#432; t&#7845;t c&#7843; các cephalosporin &#273;&#7873;u
có th&#7875; gây ph&#7843;n &#7913;ng t&#7915; gi&#7843;m b&#7841;ch c&#7847;u
trung tính &#273;&#7871;n m&#7845;t b&#7841;ch c&#7847;u h&#7841;t. T&#7845;t c&#7843;
các tr&#432;&#7901;ng h&#7907;p x&#7843;y ra &#273;&#7873;u do các li&#7873;u
tích l&#361;y cao trong m&#7897;t &#273;&#7907;t &#273;i&#7873;u tr&#7883;.
Th&#432;&#7901;ng th&#7845;y thi&#7871;u máu tan huy&#7871;t mi&#7877;n d&#7883;ch
trong quá trình &#273;i&#7873;u tr&#7883; v&#7899;i nh&#7919;ng li&#7873;u r&#7845;t
cao.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ðã có tài li&#7879;u ch&#7913;ng minh r&#7857;ng cefazolin gây c&#7843;n
tr&#7903; vi&#7879;c t&#7893;ng h&#7907;p y&#7871;u t&#7889; &#273;ông máu ph&#7909;
thu&#7897;c vitamin K. C&#7847;n l&#432;u ý theo dõi th&#7901;i gian ch&#7843;y
máu &#7903; ng&#432;&#7901;i b&#7879;nh có nguy c&#417; (ti&#7873;n s&#7917; ch&#7843;y
máu, gi&#7843;m ti&#7875;u c&#7847;u ho&#7863;c s&#7917; d&#7909;ng nh&#7919;ng
thu&#7889;c &#7843;nh h&#432;&#7903;ng &#273;&#7871;n ch&#7913;c n&#259;ng ti&#7875;u
c&#7847;u). Suy th&#7853;n, r&#7889;i lo&#7841;n ch&#7913;c n&#259;ng gan, ti&#7873;n
s&#7917; b&#7879;nh d&#7841; dày - ru&#7897;t và thi&#7871;u dinh d&#432;&#7905;ng
có th&#7875; làm t&#259;ng nguy c&#417; ch&#7843;y máu &#7903; ng&#432;&#7901;i
b&#7879;nh &#273;i&#7873;u tr&#7883; b&#7857;ng cefazolin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì có hai d&#7883; vòng &#7903; v&#7883; trí 3 và 7 và là m&#7897;t d&#7851;n
xu&#7845;t tetrazol có bi&#7875;u hi&#7879;n t&#432;&#417;ng t&#7921; v&#7899;i
phenyltetrazol gây co gi&#7853;t, nên r&#7845;t có kh&#7843; n&#259;ng
cefazolin gây c&#417;n &#273;&#7897;ng kinh. G&#7847;n &#273;ây &#273;ã có báo
cáo nh&#7919;ng tr&#432;&#7901;ng h&#7907;p b&#7883; ng&#7897; &#273;&#7897;c
th&#7847;n kinh v&#7899;i cefazolin sau khi dùng thu&#7889;c &#273;&#432;&#7901;ng
não th&#7845;t và toàn thân.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trên súc v&#7853;t, cefazolin là lo&#7841;i cephalosporin &#273;&#7913;ng
th&#7913; hai v&#7873; gây &#273;&#7897;c h&#7841;i th&#7853;n và gây
th&#432;&#417;ng t&#7893;n t&#432;&#417;ng t&#7921; nh&#432; cephaloridin. Tuy
nhiên, còn ch&#432;a bi&#7871;t rõ m&#7889;i liên quan v&#7873; tính &#273;&#7897;c
h&#7841;i này trên ng&#432;&#7901;i.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh b&#7883; suy th&#7853;n: C&#7847;n gi&#7843;m
li&#7873;u. Ph&#7843;i theo dõi ch&#7913;c n&#259;ng th&#7853;n và công th&#7913;c
máu, nh&#7845;t là khi &#273;i&#7873;u tr&#7883; li&#7873;u cao và dài ngày. N&#7871;u
ng&#432;&#7901;i b&#7879;nh b&#7883; ph&#7843;n &#7913;ng d&#7883; &#7913;ng ho&#7863;c
quá m&#7851;n nghiêm tr&#7885;ng, ph&#7843;i ng&#7915;ng s&#7917; d&#7909;ng
cefazolin và ti&#7871;n hành các bi&#7879;n pháp h&#7895; tr&#7907; (duy trì
thông khí và s&#7917; d&#7909;ng epinephrin, oxygen, tiêm t&#297;nh m&#7841;ch
steroid). <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các tr&#432;&#7901;ng h&#7907;p b&#7883; viêm &#273;&#7841;i tràng
màng gi&#7843; th&#7875; nh&#7865; th&#432;&#7901;ng ch&#7881; c&#7847;n ng&#7915;ng
thu&#7889;c. Các tr&#432;&#7901;ng h&#7907;p th&#7875; v&#7915;a và n&#7863;ng,
c&#7847;n l&#432;u ý cho dùng các d&#7883;ch ho&#7863;c ch&#7845;t &#273;i&#7879;n
gi&#7843;i, b&#7893; sung protein và &#273;i&#7873;u tr&#7883; b&#7857;ng m&#7897;t
kháng sinh có tác d&#7909;ng lâm sàng &#273;i&#7873;u tr&#7883; viêm &#273;&#7841;i
tràng do <i>Clostridium difficile</i>.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin &#273;&#432;&#7907;c tiêm b&#7855;p sâu, tiêm ch&#7853;m vào
t&#297;nh m&#7841;ch t&#7915; 3 - 5 phút ho&#7863;c tiêm truy&#7873;n t&#297;nh
m&#7841;ch. Li&#7873;u thông th&#432;&#7901;ng dùng cho ng&#432;&#7901;i l&#7899;n
là 0,5 - 1 g, 6 - 12 gi&#7901;/l&#7847;n. Li&#7873;u t&#7889;i &#273;a th&#432;&#7901;ng
dùng là 6 g/ngày, m&#7863;c dù v&#7853;y trong tr&#432;&#7901;ng h&#7907;p nhi&#7877;m
khu&#7849;n n&#7863;ng &#273;e d&#7885;a tính m&#7841;ng &#273;ã &#273;&#432;&#7907;c
dùng &#273;&#7871;n 12 g/ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Li&#7873;u s&#7917; d&#7909;ng cho tr&#7867;
s&#417; sinh d&#432;&#7899;i 1 tháng tu&#7893;i là 20 mg/kg th&#7875; tr&#7885;ng,
8 - 12 gi&#7901;/l&#7847;n. Vì tính an toàn c&#7911;a thu&#7889;c &#273;&#7889;i
v&#7899;i tr&#7867; &#273;&#7867; non d&#432;&#7899;i 1 tháng tu&#7893;i
ch&#432;a &#273;&#432;&#7907;c nghiên c&#7913;u, do &#273;ó, không khuy&#7871;n
cáo s&#7917; d&#7909;ng cefazolin cho các tr&#7867; em này.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#7867; em trên 1 tháng tu&#7893;i có th&#7875; dùng 25 - 50 mg/kg
th&#7875; tr&#7885;ng/ngày chia làm 3 ho&#7863;c 4 l&#7847;n/ngày; tr&#432;&#7901;ng
h&#7907;p nhi&#7877;m khu&#7849;n n&#7863;ng, li&#7873;u có th&#7875; t&#259;ng
lên t&#7889;i &#273;a 100 mg/kg th&#7875; tr&#7885;ng/ngày, chia làm 4 l&#7847;n/ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#7921; phòng nhi&#7877;m khu&#7849;n trong ph&#7851;u thu&#7853;t,
tiêm li&#7873;u 1g tr&#432;&#7899;c khi ph&#7851;u thu&#7853;t 0,5 - 1 gi&#7901;.
Ð&#7889;i v&#7899;i ph&#7851;u thu&#7853;t kéo dài, tiêm ti&#7871;p li&#7873;u
0,5 - 1 g trong khi ph&#7851;u thu&#7853;t. Sau ph&#7851;u thu&#7853;t tiêm li&#7873;u
0,5 - 1 g, 6 - 8 gi&#7901;/l&#7847;n trong 24 gi&#7901; ho&#7863;c trong 5 ngày
cho m&#7897;t s&#7889; tr&#432;&#7901;ng h&#7907;p (nh&#432; m&#7893; tim h&#7903;
và ghép c&#7845;y các b&#7897; ph&#7853;n ch&#7881;nh hình).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7847;n gi&#7843;m li&#7873;u cho ng&#432;&#7901;i suy th&#7853;n.
Tuy nhiên m&#7913;c gi&#7843;m li&#7873;u có nhi&#7873;u khuy&#7871;n cáo khác
nhau. Có th&#7875; s&#7917; d&#7909;ng li&#7873;u &#273;&#7873; xu&#7845;t sau
&#273;ây cho ng&#432;&#7901;i l&#7899;n sau li&#7873;u t&#7845;n công &#273;&#7847;u
tiên: Ng&#432;&#7901;i b&#7879;nh có &#273;&#7897; thanh th&#7843;i creatinin
55 ml/phút, dùng li&#7873;u thông th&#432;&#7901;ng; &#273;&#7897; thanh th&#7843;i
creatinin 35 - 54 ml/phút, dùng li&#7873;u thông th&#432;&#7901;ng v&#7899;i th&#7901;i
kho&#7843;ng gi&#7919;a hai li&#7873;u kéo dài ít nh&#7845;t là 8 gi&#7901;;
&#273;&#7897; thanh th&#7843;i creatinin 11 - 34 ml/phút, dùng 1/2 li&#7873;u
thông th&#432;&#7901;ng v&#7899;i th&#7901;i kho&#7843;ng 12 gi&#7901;/l&#7847;n;
&#273;&#7897; thanh th&#7843;i creatinin </span><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Symbol;mso-ascii-font-family:
Verdana;mso-hansi-font-family:Verdana;mso-char-type:symbol;mso-symbol-font-family:
Symbol'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>£</span></span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> 10 ml/phút, dùng 1/2 li&#7873;u thông th&#432;&#7901;ng v&#7899;i th&#7901;i
kho&#7843;ng 18 - 24 gi&#7901;/l&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pha dung d&#7883;ch tiêm tùy theo c&#7905; l&#7885;:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;text-indent:.4in;line-height:150%'><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
  path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='position:absolute;
  left:0;text-align:left;margin-left:27pt;margin-top:0;width:202.5pt;height:88.5pt;
  z-index:1'>
  <v:imagedata src="Cefazolin_files/image001.png" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0>
  <tr>
   <td width=36 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=270 height=118 src="image002-16.jpg" tppabs="http://www.vietstarse.com/duocthu/Documents/Cefazolin_files/image002.jpg" v:shapes="_x0000_s1026"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>L&#7885; 1 g ch&#7881; nên pha loãng v&#7899;i n&#432;&#7899;c
c&#7845;t tiêm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7855;c m&#7841;nh thu&#7889;c tiêm khi pha v&#7899;i dung môi.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêm b&#7855;p và tiêm t&#297;nh m&#7841;ch: Pha thu&#7889;c theo
h&#432;&#7899;ng d&#7851;n c&#7911;a b&#7843;ng pha loãng &#7903; trên. Tiêm
truy&#7873;n t&#297;nh m&#7841;ch liên t&#7909;c hay gián &#273;o&#7841;n: Pha
loãng ti&#7871;p cefazolin &#273;ã pha v&#7899;i 50 - 100 ml c&#7911;a m&#7897;t
trong nh&#7919;ng dung môi t&#432;&#417;ng h&#7907;p &#273;ã ghi &#7903; m&#7909;c:
D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7897;t s&#7889; phác &#273;&#7891; &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Viêm túi m&#7853;t c&#7845;p: Amoxicilin ho&#7863;c ampicilin tiêm t&#297;nh
m&#7841;ch 1 g, 4 - 6 gi&#7901;/l&#7847;n, cùng v&#7899;i gentamicin tiêm t&#297;nh
m&#7841;ch 4 - 5 mg/kg/ngày, li&#7873;u &#273;&#7897;c nh&#7845;t. Ho&#7863;c
cefazolin tiêm b&#7855;p 500 mg - 1 g, 8 gi&#7901;/l&#7847;n. (Tuy nhiên, cefazolin
không tác d&#7909;ng v&#7899;i <i>Enterococcus faecalis</i>).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7845;n th&#432;&#417;ng c&#417;, x&#432;&#417;ng và mô m&#7873;m,
v&#7871;t th&#432;&#417;ng, nhát &#273;âm: tác nhân gây nhi&#7877;m r&#7845;t
có th&#7875; là <i>Staphylococcus aureus, Streptococcus pyogenes</i>, <i>Clostridium
perfringens</i> và tr&#7921;c khu&#7849;n Gram âm &#432;a khí. Dùng flucloxacilin
tiêm t&#297;nh m&#7841;ch 1 g, 4 gi&#7901;/l&#7847;n, cùng v&#7899;i gentamicin
tiêm t&#297;nh m&#7841;ch 4 - 5 mg/kg th&#7875; tr&#7885;ng/ngày, tiêm 1 l&#7847;n
(ng&#432;&#7901;i l&#7899;n) ho&#7863;c chia làm hai l&#7847;n, 12 gi&#7901;/l&#7847;n,
cùng v&#7899;i metronidazol tiêm t&#297;nh m&#7841;ch 500 mg, 12 gi&#7901;/l&#7847;n.
Ho&#7863;c cefazolin, tiêm t&#297;nh m&#7841;ch 1 g, 6 gi&#7901;/l&#7847;n cùng
v&#7899;i metronidazol 500 mg, 12 gi&#7901;/l&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7851;u thu&#7853;t &#273;&#7841;i tràng - tr&#7921;c tràng và c&#7855;t
b&#7887; ru&#7897;t th&#7915;a: Dùng metronidazol qua tr&#7921;c tràng 1 g, 2 -
4 gi&#7901; tr&#432;&#7899;c ph&#7851;u thu&#7853;t cùng v&#7899;i cefazolin 1
g, tiêm b&#7855;p 1 gi&#7901; tr&#432;&#7899;c ph&#7851;u thu&#7853;t ho&#7863;c
tiêm t&#297;nh m&#7841;ch khi gây ti&#7873;n mê.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7855;t b&#7887; t&#7917; cung và tri&#7879;t s&#7843;n: Dùng
tinidazol, u&#7889;ng 2 g, 6 - 12 gi&#7901; tr&#432;&#7899;c ph&#7851;u thu&#7853;t
ho&#7863;c dùng metronidazol qua tr&#7921;c tràng 1 g, 2 - 4 gi&#7901; tr&#432;&#7899;c
ph&#7851;u thu&#7853;t cùng v&#7899;i cefazolin tiêm t&#297;nh m&#7841;ch 1 g
vào th&#7901;i gian gây ti&#7873;n mê.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7893; l&#7845;y thai: Có nguy c&#417; nhi&#7877;m khu&#7849;n cao,
dùng metronidazol tiêm t&#297;nh m&#7841;ch 500 mg, 30 phút tr&#432;&#7899;c ph&#7851;u
thu&#7853;t, cùng v&#7899;i cefazolin tiêm t&#297;nh m&#7841;ch 1g vào th&#7901;i
gian ti&#7873;n mê.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dùng ph&#7889;i h&#7907;p cefazolin v&#7899;i probenecid có th&#7875;
làm gi&#7843;m &#273;ào th&#7843;i cephalosporin qua &#7889;ng th&#7853;n, nên
làm t&#259;ng và kéo dài n&#7891;ng &#273;&#7897; cephalosporin trong máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dùng k&#7871;t h&#7907;p cephalosporin v&#7899;i colistin (m&#7897;t
kháng sinh polymyxin) làm t&#259;ng nguy c&#417; gây t&#7893;n h&#7841;i th&#7853;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7885; thu&#7889;c ch&#432;a pha: B&#7843;o qu&#7843;n tránh ánh
sáng và &#273;&#7875; &#7903; 15 - 30<sup>0</sup>C. Cefazolin &#273;ã pha trong
n&#432;&#7899;c c&#7845;t tiêm, dextrose tiêm 5%, natri clorid tiêm 0,9% gi&#7919;
&#273;&#432;&#7907;c &#7893;n &#273;&#7883;nh trong 24 gi&#7901; &#7903; nhi&#7879;t
&#273;&#7897; phòng và trong 10 ngày n&#7871;u b&#7843;o qu&#7843;n trong t&#7911;
l&#7841;nh t&#7915; 2 &#273;&#7871;n 8<sup>0</sup>C.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin natri t&#432;&#417;ng k&#7883; v&#7899;i các aminoglycosid
và nhi&#7873;u ch&#7845;t khác. Không &#273;&#432;&#7907;c tr&#7897;n cùng v&#7899;i
các kháng sinh khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>&#7902; môi tr&#432;&#7901;ng có pH trên 8,5, cefazolin có th&#7875; b&#7883;
th&#7911;y phân và &#7903; pH d&#432;&#7899;i 4,5, có th&#7875; t&#7841;o t&#7911;a
cefazolin không tan.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>X&#7917; trí quá li&#7873;u c&#7847;n &#273;&#432;&#7907;c cân nh&#7855;c
&#273;&#7871;n kh&#7843; n&#259;ng quá li&#7873;u c&#7911;a nhi&#7873;u lo&#7841;i
thu&#7889;c, s&#7921; t&#432;&#417;ng tác thu&#7889;c và d&#432;&#7907;c &#273;&#7897;ng
h&#7885;c b&#7845;t th&#432;&#7901;ng &#7903; ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#432;&#7901;ng h&#7907;p ng&#432;&#7901;i b&#7879;nh b&#7883; co gi&#7853;t,
nên ng&#7915;ng thu&#7889;c ngay l&#7853;p t&#7913;c, &#273;i&#7873;u tr&#7883;
ch&#7889;ng co gi&#7853;t n&#7871;u có ch&#7881; &#273;&#7883;nh trên lâm sàng.
B&#7843;o v&#7879; &#273;&#432;&#7901;ng hô h&#7845;p c&#7911;a ng&#432;&#7901;i
b&#7879;nh, h&#7895; tr&#7907; thông khí và truy&#7873;n d&#7883;ch. Theo dõi c&#7849;n
th&#7853;n và duy trì trong ph&#7841;m vi cho phép các bi&#7875;u hi&#7879;n s&#7889;ng
c&#7911;a ng&#432;&#7901;i b&#7879;nh, nh&#432; hàm l&#432;&#7907;ng khí - máu,
các ch&#7845;t &#273;i&#7879;n gi&#7843;i trong huy&#7871;t thanh... Tr&#432;&#7901;ng
h&#7907;p quá li&#7873;u tr&#7847;m tr&#7885;ng, &#273;&#7863;c bi&#7879;t &#7903;
ng&#432;&#7901;i b&#7879;nh suy th&#7853;n, có th&#7875; ph&#7889;i h&#7907;p l&#7885;c
máu và truy&#7873;n máu n&#7871;u &#273;i&#7873;u tr&#7883; b&#7843;o t&#7891;n
th&#7845;t b&#7841;i. Tuy nhiên, ch&#432;a có d&#7919; li&#7879;u nào &#7911;ng
h&#7897; cho cách &#273;i&#7873;u tr&#7883; này.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefazolin có trong Danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u do
Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c ph&#7843;i &#273;&#432;&#7907;c kê &#273;&#417;n và bán
theo &#273;&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cefazolin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:35 GMT -->
</html>
